Millennium Management’s MorphoSys MOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-10,414
Closed -$189K – 6701
2024
Q1
$189K Sell
10,414
-319,487
-97% -$4.72M ﹤0.01% 5397
2023
Q4
$3.27M Buy
329,901
+314,456
+2,036% +$2.31M ﹤0.01% 3166
2023
Q3
$104K Sell
15,445
-407,976
-96% -$3.14M ﹤0.01% 5325
2023
Q2
$3.16M Sell
423,421
-599,412
-59% -$3.65M ﹤0.01% 3096
2023
Q1
$4.04M Buy
1,022,833
+199,202
+24% +$878K ﹤0.01% 2794
2022
Q4
$2.95M Sell
823,631
-129,874
-14% -$581K ﹤0.01% 3229
2022
Q3
$4.8M Buy
953,505
+40,609
+4% +$210K ﹤0.01% 2926
2022
Q2
$4.42M Sell
912,896
-111,919
-11% -$618K ﹤0.01% 2934
2022
Q1
$6.95M Buy
1,024,815
+464,530
+83% +$3.43M ﹤0.01% 2582
2021
Q4
$5.28M Buy
560,285
+164,446
+42% +$1.74M ﹤0.01% 2855
2021
Q3
$4.66M Buy
395,839
+69,208
+21% +$1M ﹤0.01% 2947
2021
Q2
$6.29M Buy
326,631
+138,433
+74% +$2.96M ﹤0.01% 2452
2021
Q1
$4.1M Buy
188,198
+7,177
+4% +$192K ﹤0.01% 2793
2020
Q4
$5.13M Sell
181,021
-88,066
-33% -$2.41M ﹤0.01% 2411
2020
Q3
$8.45M Buy
269,087
+257,210
+2,166% +$8.33M 0.01% 1399
2020
Q2
$376K Sell
11,877
-21,232
-64% -$619K ﹤0.01% 3563
2020
Q1
$813K Buy
33,109
+17,603
+114% +$518K ﹤0.01% 2598
2019
Q4
$553K Sell
15,506
-51,860
-77% -$1.55M ﹤0.01% 3324
2019
Q3
$1.85M Sell
67,366
-19,412
-22% -$556K ﹤0.01% 2495
2019
Q2
$2.1M Sell
86,778
-97,937
-53% -$2.43M ﹤0.01% 2375
2019
Q1
$4.19M Buy
184,715
+8,539
+5% +$224K 0.01% 1892
2018
Q4
$4.45M Sell
176,176
-131,358
-43% -$3.45M 0.01% 1669
2018
Q3
$8.21M Sell
307,534
-24,576
-7% -$739K 0.01% 1449
2018
Q2
$10.1M Buy
+332,110
New +$9.12M 0.01% 1309

Other funds holding MOR

Millennium Management's MOR Position: Q2 2024 in Review

Millennium Management sold out of MorphoSys (MOR) in Q2 2024, closing a stake of 10,414 shares — an estimated $189K sold.

Millennium Management first reported a position in MOR in Q2 2018 and held it in 24 quarters. The position peaked at $10.1M in Q2 2018. 26 funds tracked by Wall St. Rank hold MOR as of Q2 2024.

  • Millennium Management reported no remaining MorphoSys position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 10,414 MorphoSys shares in Q2 2024, an estimated $189K.
  • Millennium Management first reported a position in MorphoSys in Q2 2018 and held it in 24 quarters.
  • Millennium Management's MorphoSys position peaked at $10.1M in Q2 2018.
  • 26 funds tracked by Wall St. Rank held MorphoSys as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.